aibio.space is an investor news site about public biotech and pharma companies. If your company is listed, it already has a profile here. Until a company takes a Company Channel, our editors manage its page. These are the ways to make sure investors see your news, your updates and the right contact.
Editors choose which companies get a full desk, based on reader interest and how much public information there is to check. A desk is written only after an editor has gone through the company's filings, pipeline and cash, with every figure linked to its source. You can ask for a desk through the company update form. Asking does not guarantee one, and a desk cannot be bought.
What makes a submission easy to use
Send the link to the primary source: the press release, the SEC or exchange filing, the ClinicalTrials.gov record or the journal paper. Say what is new and when it happened. Name a person who can answer questions. Submissions with a public source are written up fastest.
aibio